This internationally recognised meeting is focused on the transformative power of Digital Pathology and the advances created by Artificial Intelligence (AI) and Machine Learning. Across the health sector and pharmaceutical/biotech industry, the adoption of digital pathology is speeding up. It’s impact is being felt in primary diagnosis, clinical research and the laboratory.

This will be a two day meeting and exhibition with networking and drinks reception.

TOPICS COVERED

• Imaging AI & Digital Image Analysis
• Digital Pathology Implementation, Strategy & Technology
• Pharma/biotech case studies
• Computational Pathology & AI
• Applications and Research Case Studies

WHO SHOULD ATTEND?

Pathologists/Histopathologists in the health and pharmaceutical sectors, as well as Health Service Managers, Computational Biologists, AI and Machine Learning experts.

SPEAKERS INCLUDE

• Katrien Grunberg, Professor Head of the Department of Pathology at Radboudumc, Nijmegen, The Netherlands
• Andrew Janowczyk, Assistant Professor, Department of Biomedical Engineering, Emory University and Georgia Institute of Technology and Department of Oncology, Division of Precision Oncology, Department of Diagnostics, Division of Clinical Pathology, Geneva University Hospitals, Switzerland
• Peter Schirmacher, Director, Institute of Pathology, Heidelberg University Hospital; President, European Society of Pathology
• Marilyn M. Bui, Senior Member and Professor of Pathology and Machine Learning Departments, Scientific Director of Analytic Microscopy Core, Moffitt Cancer Center & Research Institute, Tampa, FL, USA; Chair of Digital and Computation Pathology Committee of CAP